AND SOLUTION RATED A+
✔✔A physician shares with your pharmacy a topical moisturizing formula which
contains a prescription drug. Which of the following would be appropriate actions for
your pharmacy to take? - ✔✔1. Fill prescriptions written by the physician for 120 grams
of this formula.
2. Prepare a pound of the formula in anticipation of additional prescriptions or refills.
✔✔Oral authorization for additional refills on a schedule III prescription are acceptable
as long as: - ✔✔1. The total quantity authorized does not exceed five re-fills within a six-
month period from the date of issue of the original prescription. 2. The quantity of each
additional refill authorized is not greater than the quantity authorized for the initial filling
of the prescription.
✔✔Controlled substance prescriptions: - ✔✔1. May be written by typewriter (except for
the prescriber's signature)
2. Must have the name of the physician printed, stamped, typed, or hand-printed on it.
3. May be prepared by an agent of the prescriber for the prescriber's signature.
✔✔The use of an FDA approved drug for a use that is not approved for the drug is best
described as being: - ✔✔*Off-label*
✔✔The Electronic Orange Book uses the symbol ''RLD'', in a series of similar drug
products to indicate: - ✔✔*The product used as a reference standard*
✔✔Which of the following entities must register in order to participate in the prescribing
or dispensing of isotretinoin? - ✔✔1. *Prescribers*
2. *Pharmacies*
3. *Drug wholesalers*
✔✔The body that is responsible for overseeing the selection of a nonproprietary name
for a new drug is the: - ✔✔a. FDA
b. FTC
c. APhA
d. USP/NF
e. *USAN*
✔✔Federal guidelines indicate that the pharmacist should indicate the date on which a
prescription refill is dispensed: - ✔✔*On the back of the paper prescription*
✔✔Which one of the following pieces of information is *not* encoded into a drug
product's NDC? - ✔✔a. Drug name
b. Manufacturer
,c. Package size
d. *Product's Expiration Date*
e. Strength of a tablet
✔✔Refusal of a patient to provide medical information for a patient prescription profile
means that the pharmacist: - ✔✔*Can fill the prescription at his/her discretion*.
✔✔"Grandfathered" drugs are: - ✔✔*Often not listed in the Orange Book*
✔✔Which of the FF is/are used in the treatment of narcotic dependence? - ✔✔1.
*Naltrexone*
2. *Methadone*
3. *Buprenorphine*
✔✔Which of the FF statements concerning bar coding of prescription drug labels is/are
accurate? - ✔✔1. *The products expiration date may be included in the bar code* 2.
*Labels of vaccine products must be bar coded*
✔✔According to Federal regulations, a color additive may not be added to which one of
the following dosage forms? - ✔✔*Parenteral Solutions*
✔✔A customer enters your pharmacy and requests 25 quinine 260 mg tablets. Which of
the following responses by the pharmacist would be appropriate? - ✔✔1. *Quinine
tablets can no longer be sold over-the-counter*.
2. *OTC quinine is considered to be unsafe for the prevention of malaria*.
3. *OTC quinine is considered ineffective for the treatment of nocturnal leg cramps*.
✔✔What is the longest "beyond use" expiration date that a pharmacist may place on a
prescription container if the original drug container label states "expiration date 1/2017"?
Assume the pharmacist fills the prescription on January 2, 2014. - ✔✔a. 7/2/14
b. *1/2/15*
c. 7/2/15
d. 1/1/17
e. 1/31/17
✔✔The Consumer Product Safety Commission is responsible for which one of the
following? - ✔✔*Poison Prevention Packaging Act*
✔✔How often must a pharmacy have a patient sign a new notice that he/she has been
informed of the pharmacy's privacy practices under HIPAA requirements? - ✔✔*No
requirements are specific by HIPAA*
✔✔How may a physician obtain cocaine HCL powder for use as a local anesthetic in his
office? - ✔✔By ordering it directly from a supplier using DEA Form 222
, ✔✔Evidence indicates that a marketed drug product may have a new use for another
condition. In order to claim this new indication, a drug manufacturer must: - ✔✔*Submit
a supplemental NDA*
✔✔Blood and/or urine tests are frequently performed on participants in comprehensive
narcotic maintenance treatment programs in order to detect: - ✔✔*Continued Abuse of
Drugs*
✔✔Which one of the following acronyms is most closely associated with health care
reimbursement? - ✔✔a. *DRG* [Diagnosis-Related Group]
b. DEA
c. GMP
d. JCAHO
e. PPI
✔✔In the U.S., which of the following commercial drug products intended for oral
administration must have an identifying imprint on each individual dosage? - ✔✔1.
*Nonprescription tablets*
2. *Prescription tablets*
3. *Prescription capsules*
✔✔A filled DEA Form 222 must be kept by the: - ✔✔*Purchase for 3 years*
✔✔Sponsors of Medicare Plan D programs must provide a broad choice of formulary
drugs for each of the following drug categories except: - ✔✔a. Anticonvulsants
b. Antidepressants
c. *Antihyperlipidemics*
d. Antineoplastics
e. Antipsychotics
✔✔Which one of the FF dosage forms is *Least* likely to present bioequivalence
problems? - ✔✔a. capsule
b. Tablet
c. Suspension
d. Transdermal patch
e. *IV solution*
✔✔Which of the FF is/are Schedule IV controlled substances? - ✔✔a. *Zaleplon*
b. Buprenorphine
c. Methylphenidate
✔✔Which one of the following actions is permissible in a hospital that has tax-free
alcohol? - ✔✔*Dispensing to inpatients in the form of a tonic*